C07D 515/14
Ortho-condensed systems
C07D515/14 (Ortho-condensed systems) appears on 28 US grants and 31 published applications in this corpus.
Search patents in C07D- Granted patents
- 28
- Published applications
- 31
- Assignees
- 26
- Inventors
- 140
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 2 | 2 |
| 2020 | 0 | 2 |
| 2021 | 3 | 7 |
| 2022 | 3 | 5 |
| 2023 | 1 | 4 |
| 2024 | 6 | 5 |
| 2025 | 3 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hybrid cyclic libraries and screens thereof3 Mar 2026US 12,565,518 B2The Johns Hopkins University
- Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors20 Jan 2026US 12,528,827 B2Bristol-Myers Squibb Company
- Oxalamido-substituted tricyclic inhibitors of hepatitis b virus11 Nov 2025US 12,465,590 B2Irbm S.P.A.
- Spirocyclic inhibitors of hepatitis B virus2 Sep 2025US 12,404,284 B2Istituto Nazionale Genetica Molecolare - Ingm
- BCL-2 inhibitors11 Feb 2025US 12,220,419 B2Newave Pharmaceutical Inc.
- Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors19 Sep 2024US 2024/0309019 A1Bristol-Myers Squibb Company
- Hybrid cyclic libraries and screens thereof8 Aug 2024US 2024/0262867 A1The Johns Hopkins University
- Bcl-2 inhibitors6 Jun 2024US 2024/0180924 A1Newave Pharmaceutical Inc.
- Macrocycles and their use6 Jun 2024US 2024/0182487 A1Blossomhill Therapeutics, Inc.
- Modulators of cystic fibrosis transmembrane conductance regulator18 Jan 2024US 2024/0018161 A1Vertex Pharmaceuticals Incorporated
Most cited
By later US patents
- Hybrid cyclic libraries and screens thereof36US 9,250,237 B2The Johns Hopkins University · 2016
- Antiviral eudistomins from a marine tunicate24US 4,631,149 AUniversity of Illinois · 1986
- Cytostatic beta-carbolines6US 5,095,020 ADuphar International Research B.V. · 1992
- Condensed pyridoindole derivatives6US 6,858,620 B2Lilly ICOS LLC · 2005
- Di- and tetrahydroisoquinoline derivatives5US 5,162,335 ADuphar International Research B.V. · 1992